Brainchip (ASX:BRN) share price shoots 9% higher on software development centre

The Brainchip share price has jumped 9.3% to 47 cents following news the company has established a software development centre in India.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Brainchip Holdings Ltd (ASX: BRN) share price has jumped 9.3% to 47 cents at the time of writing. The sharp Brainchip share price movement comes following an announcement of the company establishing a software development centre.

This compares with the All Ordinaries Index (ASX: XAO) which is down 0.73% to 6,025 points.

A man looks stunned as a cloud explodes from his head representing the CogState share price crashing today in

Image source: Getty Images

Brainchip presence in India

In mid-afternoon trade, the Brainchip share price is surging after the company advised the market it has established a software development centre in Hyderabad, India. A leading provider of ultra-low power, high performance artificial intelligence (AI) technology, Brainchip will seek to support development of its Akida Neuromorphic System-on-Chip (NSoC).

The new asset addition is expected to concentrate on the software and firmware development of the Akida NSoC. This includes critical components such as software for device drivers, the CPU complex and firmware for commercial implementation.

The development centre will be staffed by five software engineers and local management. Brainchip said that it does not expect the new entity to add any incremental expenses to its historical cash flows. This is due to staff having previously served the company as contracted service providers over several quarters.

Brainchip also stated that it has provided funds for the new facility and cost of equipment.

The company's India division will complement the team in France, which hones in on the software environment and networks on the Akida neuron fabric. The implementation is intended to provide ease of use and execution in leveraging ultra-low power, event-based capability.

What did management say?

Brainchip CEO, Louis DiNardo, validated the company's new establishment to shareholders. He said:

We have established BrainChip Systems India to support the requirement for robust system software and firmware. As Akida is implemented commercially, it is important that our software is mature and provides a positive user experience.

Furthermore, Mr DiNardo commented:

We have a very seasoned management and engineering team in Hyderabad. Having a BrainChip entity in India will allow us to recruit and retain experienced engineering professionals as we expand operations to meet market demands. The India group has been working exclusively on Akida software and firmware development for several quarters and we are fortunate to have them join us as we bring Akida to market.

Is the Brainchip share price too cheap to ignore?

The Brainchip share price has taken shareholders on a wild ride in recent times. Brainchip shares started the year at 4.7 cents, and climbed to an all-time high of 97 cents. However, the last two weeks of heavy selling in Brainchip shares have been attributed to profit takers. Nonetheless, the Brainchip share price is still up over 1000% in the last nine months.

In my opinion, Brainchip has a lot of promise that could one day see it become a multibillion-dollar market cap share. Its advanced Akida chip may offer huge advantages for company projects such as NASA's future missions.

At a market capitalisation of $700 million, Brainchip is still a small-cap share that is growing. Should the company be able to deliver on its potential, I think that the Brainchip share price is extremely attractive at a price of 47 cents.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Man in a business suit leaps off a boulder in front of a blue sky.
Energy Shares

How is this ASX energy share leaping 17% in Monday's sinking market?

Up 263% in a year, this ASX energy share is smashing the benchmark again today. But why?

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Life360, Magellan, and QBE shares

Are analysts bullish or bearish on these names? Let's find out.

Read more »

aHands pretending to hold the sun with a graphic love heart on top.
Opinions

2 top ASX shares to buy and hold for the next decade

I’m backing these investments for long-term returns.

Read more »

A silhouette shot of two business man shake hands in a boardroom setting with light coming from full length glass windows beyond them.
Share Market News

Perpetual sells Wealth Management business to Bain Capital for $500m

Perpetual is selling its Wealth Management arm to Bain Capital in a strategic move to simplify the business and focus…

Read more »

A hipster-looking man with bushy beard and multiple arm tattoos sits on the floor against a sofa reading a tablet with his hand on his chin as though he is deep in thought.
Share Market News

Orica settles US litigation and announces US acquisition

Orica announces a major US litigation settlement and a new US business acquisition, both set to strengthen its North American…

Read more »

Man going down a red arrow, symbolising a sliding share price.
Share Market News

3 ASX shares slide after being cut from the ASX 200

ASX 200 exits often cause short-term pressure. Long-term prospects remain unchanged.

Read more »

a close up of two people shake hands in front of the backdrop of a setting sun in an outdoor setting.
Share Market News

Lynas Rare Earths announces US$96m US rare earth agreement

Lynas Rare Earths has signed a major US rare earth supply deal, with a US$96m US Government offtake and four-year…

Read more »

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
Share Market News

Telix Pharmaceuticals resubmits FDA application for brain cancer imaging agent

Telix Pharmaceuticals has resubmitted its FDA application for TLX101-Px, a new brain cancer imaging candidate.

Read more »